Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Prospective, multi-center open label study of HLA-partially to fully matched allogeneic cryopreserved deceased donor bone marrow transplantation and living donor transplantation for patients with hematologic malignancies.

Participants needed: 300
Trial details
Age: 12-75Biological sex: AllType: InterventionalSponsor: Ossium Health, Inc.Updated: Jul 20, 2026
Eligibility criteria

Patient has the ability to provide informed consent according to the applicable... [+23]

Autologous transplant within 6 months [+12]

Status: Recruiting

HPC Offered for PRESERVE Expansion

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Participants needed: 10
Trial details
Age: 12-80Biological sex: AllType: ObservationalSponsor: Ossium Health, Inc.Updated: Aug 28, 2025Locations: 4Duration: 1 Year
Eligibility criteria

Not listed